Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vaginal Misoprostol vs Dinoprostone in Term Pregnancies
NCT00432588Phase 2Unknown
- Sponsor
- Hormozgan University of Medical Sciences
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of misoprostol in preeclampsia, premature rupture of membranes (PROM) and fetal death (IUFD) (3 arms), sponsored by Hormozgan University of Medical Sciences. Primary endpoints: Duration of Labor and Obstetric Complications. Status: unknown.
02
Drugs
misoprostol
03
Conditions
preeclampsiapremature rupture of membranes (PROM)fetal death (IUFD)
Beyond the preview
Go deeper on NCT00432588.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00432588.